Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Prader-Willi and Angelman syndromes — formative SAQs

Formative SAQs on recognising Prader-Willi syndrome in the neonate, recognising Angelman syndrome in the toddler, confirming the molecular diagnosis with methylation analysis, determining the molecular subtype for recurrence-risk counselling, and building syndrome-specific multidisciplinary management.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Prader-Willi and Angelman syndromes

SAQ 1 (10 marks)

A two-week-old neonate is referred for profound hypotonia, poor feeding, and a weak cry. Birth weight was at the 10th centile. He requires nasogastric feeding. Examination reveals a narrow bifrontal diameter, almond-shaped palpebral fissures, a thin upper lip, bilateral cryptorchidism, and acromicria. A standard karyotype has been reported as normal. [1] [3]

a) Give the most likely diagnosis and explain why a normal karyotype does not exclude it. Name the first-tier molecular test you will order. (3 marks) [1] [4]

b) Describe the three molecular subtypes of this syndrome, their approximate relative frequencies, and the mechanism by which each produces the phenotype. (3 marks) [3] [4]

c) Outline the syndrome-specific management plan for this child across infancy and childhood, naming four domains that require active intervention. (2 marks) [1] [7]

d) Explain why molecular subtype determination is essential for genetic counselling, and state the recurrence risk for each subtype. (2 marks) [4]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Driscoll DJ, Miller JL, Cassidy SB Prader-Willi Syndrome. GeneReviews, 1993.PMID 20301505
  2. [2]Dagli AI, Mathews J, Williams CA Angelman Syndrome. GeneReviews, 1993.PMID 20301323
  3. [3]Cassidy SB. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting. Medicine, 1998.PMID 9556704
  4. [4]Beygo J, et al. Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes. Eur J Hum Genet, 2019.PMID 31235867
  5. [6]Duis J, et al. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med, 2022.PMID 35150089
  6. [7]Koch L. Consensus guidelines for GH therapy in Prader-Willi syndrome. Nat Rev Endocrinol, 2013.PMID 23609333
  7. [9]Manssen L, Krey I, Gburek-Augustat J, et al. Precision Medicine in Angelman Syndrome. Neuropediatrics, 2025.PMID 39168152
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPeroxisomal disorders — formative SAQsgenetics-dysmorphology-and-metabolismNextPrenatal diagnosis and reproductive genetics — formative SAQsgenetics-dysmorphology-and-metabolism